Exprimary

ExPrimary, Inc. is revolutionizing the bioanalysis sector by developing high-performance instrumentation and state-of-the-art assay content at significantly lower costs compared to existing products. The company aims to democratize access to advanced bioanalytical tools, catering to both research and diagnostic markets. By focusing on personalized healthcare, ExPrimary addresses the increasing demand for precise and cost-effective bioanalytical solutions. The business model revolves around the sale of cutting-edge instruments and assays, targeting academic institutions, healthcare providers, and biotech companies. Revenue is generated through direct sales, subscriptions, and service contracts. The company operates in the biotechnology and healthcare markets, positioning itself as a key player in the advancement of personalized medicine.

Keywords: bioanalysis, instrumentation, assays, personalized healthcare, research, diagnostics, biotechnology, cost-effective, advanced tools, healthcare providers.